After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$85.74K

Mahon Paul A EVP & General Counsel

Transaction date Jun 18, 2026
Public filing date Jun 18, 2026
Filing lag Filed same day

UTHR daily price context

Close on/before transaction
$536.59 Jun 18, 2026
First close after public filing
$538.3 Jun 22, 2026
30-day return after filing
-1.66% Through Jul 20, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
157 shares @ $546.15
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001231589-26-000014
Filing cohort

Transactions in this filing

Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$5.71M
Buys / sales
0 / 11
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jun 18, 2026 $1.21M
United Therapeutics Corp UTHR Sale Jun 18, 2026 $921.03K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $515.43K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $703.94K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $431.12K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $514.19K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $86.71K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $261.25K
United Therapeutics Corp UTHR Current Sale Jun 18, 2026 $85.74K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $482.48K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $272.26K
United Therapeutics Corp UTHR Sale Jun 18, 2026 $220.7K
United Therapeutics Corp UTHR Exercise Jun 18, 2026 $0